EUVIMEDEUVIMED entdecken
Crossref

AB003. Adjuvant treatment pathways and disease control after R0 resection for thymic squamous cell carcinoma

Zhiheng Yao, Hongmu Li, Zhenyuan Yang, Yiling Cai, Leqi Zhong, Zhenyu Zhao, Weichen Liu, Weixiong Yu, Bin Zheng, Chun Chen

Mediastinum · 2026-10 · 10 · AB003-AB003

DOI: 10.21037/med-26-ab003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediastinum, 2026-10. Verfasst von Zhiheng Yao und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yao, Z., Li, H., Yang, Z., Cai, Y., Zhong, L., Zhao, Z., Liu, W., Yu, W., Zheng, B., & Chen, C. (2026). AB003. Adjuvant treatment pathways and disease control after R0 resection for thymic squamous cell carcinoma. Mediastinum, 10, AB003-AB003. https://doi.org/10.21037/med-26-ab003

Vancouver

Yao Z, Li H, Yang Z, Cai Y, Zhong L, Zhao Z, et al. AB003. Adjuvant treatment pathways and disease control after R0 resection for thymic squamous cell carcinoma. Mediastinum. 2026;10:AB003-AB003. doi:10.21037/med-26-ab003

BibTeX
@article{Yao2026,
  author = {Yao, Zhiheng and Li, Hongmu and Yang, Zhenyuan and Cai, Yiling and Zhong, Leqi and Zhao, Zhenyu and Liu, Weichen and Yu, Weixiong and Zheng, Bin and Chen, Chun},
  title = {AB003. Adjuvant treatment pathways and disease control after R0 resection for thymic squamous cell carcinoma},
  journal = {Mediastinum},
  year = {2026},
  volume = {10},
  pages = {AB003--AB003},
  doi = {10.21037/med-26-ab003}
}
Kostenlos starten →